The German “sibling” to our HealthNewsReview.org project launched today –
http://www.medien-doktor.de. While the site is in German, the Google Translate tool does an adequate job in translating it for those who don’t speak auf Deutsch.
“…a unique monitoring project observing medical coverage in German media starts: A team of respected medical and science journalists regularly evaluates selected articles from newspapers, magazines, TV, radio and the internet. The evaluations, comments and further recommendation are published on the website www.medien-doktor.de Each evaluation is based on an internationally approved catalogue of quality criteria which was extended and refined at the Chair for Science Journalism at Dortmund University (TU Dortmund) in cooperation with the reviewers of the project. Details about the project are presented at a press conference during one of the biggest meetings of science journalists in Europe , the”WissensWerte”in the Congress Center Bremen on November 8th 2010 (5 p.m.). The German project was inspired by similar projects in Australia, Canada and the US (www.healthnewsreview.org ).”
When I consulted with the German team in Dortmund in September, I asked Professor Holger Wormer, a longtime science journalist, what his message would be to German journalists who have not yet seen the website.
Website publisher Marcus Anhäuser, a freelance science journalist, discussed one topic on which he hopes to generate more discussion – the limitations of brief stories that don’t offer enough background, analysis or context.
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like